Commerzbank Reiterates €211.00 Price Target for Hypoport (HYQ)

Share on StockTwits

Hypoport (ETR:HYQ) has been given a €211.00 ($245.35) target price by analysts at Commerzbank in a research report issued on Thursday, September 27th. The brokerage currently has a “neutral” rating on the stock. Commerzbank’s target price indicates a potential upside of 18.41% from the company’s current price.

Other equities analysts also recently issued research reports about the stock. Warburg Research set a €190.00 ($220.93) price target on shares of Hypoport and gave the company a “buy” rating in a report on Monday, August 6th. Berenberg Bank set a €174.00 ($202.33) price target on shares of Hypoport and gave the company a “neutral” rating in a report on Thursday, July 19th. Oddo Bhf set a €191.00 ($222.09) price target on shares of Hypoport and gave the company a “neutral” rating in a report on Wednesday, August 8th. Finally, equinet set a €190.00 ($220.93) price target on shares of Hypoport and gave the company a “neutral” rating in a report on Tuesday, August 21st. Four equities research analysts have rated the stock with a hold rating and one has issued a buy rating to the company. Hypoport currently has an average rating of “Hold” and an average price target of €192.40 ($223.72).

Shares of HYQ traded up €2.60 ($3.02) during trading hours on Thursday, reaching €178.20 ($207.21). The company had a trading volume of 17,587 shares, compared to its average volume of 9,727. Hypoport has a 12-month low of €83.60 ($97.21) and a 12-month high of €164.00 ($190.70).

Hypoport Company Profile

Hypoport AG operates as a technology-based financial service provider in Germany. The company operates through four business units: Credit Platform, Financial Product Sales ? Institutional Clients, Financial Product Sales – Private Clients, and Insurance Platform. It offers EUROPACE marketplace for independent distributors to process their financing transactions with the product suppliers they represent.

Recommended Story: Compound Annual Growth Rate (CAGR)

Analyst Recommendations for Hypoport (ETR:HYQ)

Receive News & Ratings for Hypoport Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypoport and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.